These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

882 related items for PubMed ID: 15950314

  • 1. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW.
    Adv Drug Deliv Rev; 2005 Jul 29; 57(10):1539-50. PubMed ID: 15950314
    [Abstract] [Full Text] [Related]

  • 2. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P, Allison DG, McBain AJ.
    J Appl Microbiol; 2002 Jul 29; 92 Suppl():98S-110S. PubMed ID: 12000619
    [Abstract] [Full Text] [Related]

  • 3. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
    Tamilvanan S, Venkateshan N, Ludwig A.
    J Control Release; 2008 May 22; 128(1):2-22. PubMed ID: 18342974
    [Abstract] [Full Text] [Related]

  • 4. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL, Patel R.
    Clin Pharmacol Ther; 2007 Aug 22; 82(2):204-9. PubMed ID: 17538551
    [Abstract] [Full Text] [Related]

  • 5. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P, Allison DG, McBain AJ.
    Symp Ser Soc Appl Microbiol; 2002 Aug 22; (31):98S-110S. PubMed ID: 12481835
    [Abstract] [Full Text] [Related]

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 22; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
    Keays T, Ferris W, Vandemheen KL, Chan F, Yeung SW, Mah TF, Ramotar K, Saginur R, Aaron SD.
    J Cyst Fibros; 2009 Mar 22; 8(2):122-7. PubMed ID: 19064337
    [Abstract] [Full Text] [Related]

  • 8. Needed, new paradigms in antibiotic development.
    Ceri H, Olson ME, Turner RJ.
    Expert Opin Pharmacother; 2010 Jun 22; 11(8):1233-7. PubMed ID: 20384540
    [Abstract] [Full Text] [Related]

  • 9. Effect of antibacterials on biofilms.
    Aslam S.
    Am J Infect Control; 2008 Dec 22; 36(10):S175.e9-11. PubMed ID: 19084156
    [Abstract] [Full Text] [Related]

  • 10. Biofilms--a neglected antibacterial target?
    Toney JH.
    Curr Opin Investig Drugs; 2007 Aug 22; 8(8):598-9. PubMed ID: 17668361
    [No Abstract] [Full Text] [Related]

  • 11. The physiology and collective recalcitrance of microbial biofilm communities.
    Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW.
    Adv Microb Physiol; 2002 Aug 22; 46():202-56. PubMed ID: 12073654
    [Abstract] [Full Text] [Related]

  • 12. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V, Chifiriuc MC.
    Roum Arch Microbiol Immunol; 2010 Aug 22; 69(3):125-38. PubMed ID: 21434589
    [Abstract] [Full Text] [Related]

  • 13. [Biofilm--still a problem?].
    Skrlin J.
    Lijec Vjesn; 2010 Aug 22; 132 Suppl 1():24-6. PubMed ID: 20715715
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal.
    Landini P, Antoniani D, Burgess JG, Nijland R.
    Appl Microbiol Biotechnol; 2010 Apr 22; 86(3):813-23. PubMed ID: 20165945
    [Abstract] [Full Text] [Related]

  • 15. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections.
    Rice SA, McDougald D, Kumar N, Kjelleberg S.
    Curr Opin Investig Drugs; 2005 Feb 22; 6(2):178-84. PubMed ID: 15751741
    [Abstract] [Full Text] [Related]

  • 16. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA.
    Nature; 2003 Nov 20; 426(6964):306-10. PubMed ID: 14628055
    [Abstract] [Full Text] [Related]

  • 17. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms.
    Slinger R, Chan F, Ferris W, Yeung SW, St Denis M, Gaboury I, Aaron SD.
    Diagn Microbiol Infect Dis; 2006 Nov 20; 56(3):247-53. PubMed ID: 16769194
    [Abstract] [Full Text] [Related]

  • 18. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS, Abbanat D.
    Expert Opin Ther Pat; 2010 Oct 20; 20(10):1373-87. PubMed ID: 20636186
    [Abstract] [Full Text] [Related]

  • 19. Biofilms and their relevance to veterinary medicine.
    Clutterbuck AL, Woods EJ, Knottenbelt DC, Clegg PD, Cochrane CA, Percival SL.
    Vet Microbiol; 2007 Mar 31; 121(1-2):1-17. PubMed ID: 17276630
    [Abstract] [Full Text] [Related]

  • 20. Biofilms and infections of the upper respiratory tract.
    Pintucci JP, Corno S, Garotta M.
    Eur Rev Med Pharmacol Sci; 2010 Aug 31; 14(8):683-90. PubMed ID: 20707288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.